More PRNewswire
View Older Stories View Newer Stories-
Bloomberg Expands HQLA Solution to Middle East as International Banks Increase Presence in Region
-
CME Group Announces Record Volume, Open Interest Across Battery Metals Complex
-
Markel announces completion of MECO acquisition
-
Markets4you Celebrates 18 Years with Global Recognition, New Features, and Expanded Trading Options
-
iOnctura bolsters leadership team with new appointments
-
Lexsoft Evolves Legal Knowledge Management Into a "Knowledge Research" Discipline With Release of T3 GenAI Version 2
-
Truecaller reaches two new milestones for consumer subscriptions
-
Clarivate and CAPES Expand Landmark Partnership to Power Research and Innovation Across Brazil
-
Swire Energy Services to be acquired by Davidson Kempner
-
STARTUP AUTOBAHN powered by Plug and Play Showcases Over 30 Pilot Projects Between Mobility Leaders and Startups at expo2025
-
Equiduct unveils new visual identity, revamped website and updated Market Viewer
-
The Frequency School breaks GUINNESS WORLD RECORDS™ title for the "195" song featuring the most nationalities
-
Repurchase of Truecaller B shares in week 22, 2025
-
Paratus: Transactions Made Under Share Buyback Program and Completion of Program
-
Indivior Announces Intention to Cancel Secondary Listing on London Stock Exchange; Primary Listing on Nasdaq to be Maintained
-
Injured on a Cruise? Law Offices of Jason Turchin has Cruise Lawyers to Help to Passengers Hurt on a Cruise
-
Sanofi to acquire Blueprint Medicines, expanding portfolio in rare immunological disease and adding early-stage pipeline in immunology
-
Flex LNG - Finalize $175 million lease financing for Flex Courageous
-
Visby Management Reiterates Superior Offer to LCL Resources
-
Fintech's Next Chapter: Profits Rise, AI Reshapes the Landscape, and Scaled Winners Come of Age
-
CMO Confidence in GenAI Is Higher Than Ever, with Over 80% Expressing Optimism
-
Private equity upturn hit by tariff turmoil, but winning firms will lean into turbulence to seize opportunities amid the uncertainty--Bain & Company's PE Midyear Report
-
How are global cities building a shared future with Shanghai？
-
J INTS BIO to Present Global Clinical Results from JIN-A02, a Fourth-Generation EGFR-TKI, at ASCO 2025
-
Peacock 1953 Aircraft Hand Watch: Heritage Meets Horological Innovation in a Tribute to China's Watchmaking Pioneers
-
CARsgen Presents Research Results on Satri-cel in The Lancet and at the 2025 ASCO Annual Meeting
-
2025 ASCO Oral Presentation: Innovent Biologics Announces Updated Date of IBI363 (First-in-class PD-1/IL-2α-bias Bispecific Antibody Fusion Protein) from Phase 1 Clinical Studies in Advanced Colorect
-
Europe's Moonshot Moment: New Industry Report Suggests Now is Europe's Time to Lead in Global Software
-
Zareef Hamid on the Rise of AI-Native Organizations
-
Guard Your Card Illinois: Illinois General Assembly Delays Implementation of Flawed Interchange Fee Prohibition Act
-
Monster Energy Athletes Claim Podium Spots at 2025 UCI Downhill Mountain Bike World Cup in Loudenvielle-Peyragudes
-
Trevi Therapeutics to Host Conference Call and Webcast on June 2nd to Share Topline Results from the Phase 2b CORAL Trial of Haduvio in Patients with Idiopathic Pulmonary Fibrosis Chronic Cough
-
HORIZON PETROLEUM PROVIDES AN OPERATIONS UPDATE OF ITS PREPARATION FOR FIRST PRODUCTION IN POLAND
-
Constellis announces new offerings from Constellis Advisors & Training
-
The Academy of Oncology Nurse & Patient Navigators and Gilead Sciences Partner to Launch Oncology Navigation Grant Program
-
Celestine Achi Launches Free AI Readiness Assessment Tool and Maturity Framework to Accelerate Africa's AI Adoption in PR, Media, and Communications
-
Xinhua Silk Road: 21st Shanghai Suzhou Creek Dragon Boat Invitational Tournament concludes with record participation
-
Deepcoin Launches Futuristic Website & App Redesign to Power a High-Performance Trading Experience
-
Thyme Care Triples Its Multidisciplinary Care Team with Increased Focus on Often-Overlooked Survivorship Population
-
Taiho Oncology and Cullinan Therapeutics Announce Pivotal REZILIENT1 Phase 1/2 Data Published in the Journal of Clinical Oncology
-
Johnson & Johnson unveils first-in-human results for pasritamig, showing early anti-tumor activity in prostate cancer
-
China Liberal Education Holdings Limited Announces Suspension of Nasdaq Trading
-
Transform Your Workspace: Madison Liquidators Announces $5,000 Office Makeover Giveaway
-
In New Awareness Campaign, Yara Shahidi Reflects on Growth, Education, and Pursuing Passion
-
Sancrox Political Advisory: Voters rally around Oyun-Erdene ahead of vote of no confidence
-
Blokees made its debut at CCXP México 2025, Officially Enters México Market
-
InxMed Announces Promising Phase Ib/II Clinical Data for Ifebemtinib + KRAS G12C inhibitor in KRAS G12C-Mutant Solid Tumors at ASCO 2025
-
ASCO 2025 Oral Presentation: Innovent Biologics Announces Updated Data of IBI363 (First-in-class PD-1/IL-2α -bias Bispecific Antibody Fusion Protein) from Phase 1 and 2 Clinical Studies on Immunother
-
Zeekr Group Announces May 2025 Delivery Update
-
Novoxel Inc. and GPOphtho Finalize Strategic Agreement to Deliver Breakthrough Dry Eye Treatments and Aesthetic Procedures to Eyecare Physicians Nationwide
